Neuro-Oncology Reviews
Volume
25 Number 1
15 January 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 1, 15 January
Cano A,
Ettcheto M, Bernuz M, Puerta R, Esteban de Antonio E,
Sánchez-López E, Souto EB, Camins A, Martí M,
Pividori MI, Boada M, Ruiz A.
Extracellular
vesicles, the emerging mirrors of brain physiopathology.
Int
J Biol Sci. 2023 Jan 1;19(3):721-743∟.
doi: 10.7150/ijbs.79063∟.
PMID: 36778117∟.
Review. ˍ
Laurenge A, Huillard E, Bielle F,
Idbaih A.
Cell
of Origin of Brain and Spinal Cord Tumors.
Adv
Exp Med Biol. 2023 Jan 2, 2023;1394:85-101∟.
doi: 10.1007/978-3-031-14732-6_6∟.
PMID: 36587383∟.
Review˰ ˍ
Medikonda R, Pant A, Lim
M.
Immunotherapy
as a New Therapeutic Approach for Brain and Spinal Cord
Tumors.
Adv Exp
Med Biol. 2023 Jan 2, 2023;1394:73-84∟.
doi: 10.1007/978-3-031-14732-6_5∟.
PMID: 36587382∟.
Review˰ ˍ
Shobeiri P, Seyedmirzaei H,
Kalantari A, Mohammadi E, Rezaei N, Hanaei S.
The
Epidemiology of Brain and Spinal Cord Tumors.
Adv
Exp Med Biol. 2023 Jan 2, 2023;1394:19-39∟.
doi: 10.1007/978-3-031-14732-6_2∟.
PMID: 36587379∟.
Review˰ ˍ
Walbert T, Stec NE.
Palliative
care in brain tumors.
Handb
Clin Neurol. 2023 Jan 2, 2023;191:69-80∟.
doi: 10.1016/B978-0-12-824535-4.00011-2∟.
PMID: 36599516∟.
Review˰ ˍ
Yoon WS, Chung DS.
Advanced
T and NK Cell Therapy for Glioblastoma.
J
Korean Neurosurg Soc. 2023 Jan 2∟.
doi: 10.3340/jkns.2022.0267∟.
PMID: 36588388∟.
Review. ˍ
Chai R, Fang
S, Pang B, Liu Y, Wang Y, Zhang W, Jiang T.
Molecular
pathology and clinical implications of diffuse glioma.
Chin
Med J (Engl). 2023 Jan 3∟.
doi: 10.1097/CM9.0000000000002446∟.
PMID: 36728558∟.
Review. ˍ
Khan F, Pang L, Dunterman M,
Lesniak MS, Heimberger AB, Chen P.
Macrophages
and microglia in glioblastoma: heterogeneity, plasticity, and
therapy.
J Clin
Invest. 2023 Jan 3, 2023;133(1):e163446∟.
doi: 10.1172/JCI163446∟.
PMID: 36594466∟.
Review. ˍ
Friedmann-Morvinski D,
Hambardzumyan D.
Monocyte-neutrophil
entanglement in glioblastoma.
J
Clin Invest. 2023 Jan 3, 2023;133(1):e163451∟.
doi: 10.1172/JCI163451∟.
PMID: 36594465∟.
Review. ˍ
Li S, Wang C, Chen J, Lan Y, Zhang
W, Kang Z, Zheng Y, Zhang R, Yu J, Li W.
Signaling
pathways in brain tumors and therapeutic interventions.
Signal
Transduct Target Ther. 2023 Jan 4, 2023;8(1):8∟.
doi: 10.1038/s41392-022-01260-z∟.
PMID: 36596785∟.
Review. ˍ
Shu L, Yu D,
Jin F.
Healthy
dietary patterns, foods, and risk of glioma: A systematic review
and meta-analysis of observational studies.
Front
Nutr. 2023 Jan 4, 2022;9:1077452∟.
doi: 10.3389/fnut.2022.1077452∟.
PMID: 36687697∟.
Review, Meta-analysis. ˍ
Vetkas A,
Germann J, Boutet A, Samuel N, Sarica C, Yamamoto K, Santyr B,
Cheyuo C, Conner CR, Lang SM, Lozano AM, Ibrahim GM, Valiante T,
Kongkham PN, Kalia SK.
Laser
interstitial thermal therapy for the treatment of insular lesions:
A systematic review.
Front
Neurol. 2023 Jan 4, 2022;13:1024075∟.
doi: 10.3389/fneur.2022.1024075∟.
PMID: 36686528∟.
Review. ˍ
Ninatti G,
Pini C, Gelardi F, Sollini M, Chiti A.
The
Role of PET Imaging in the Differential Diagnosis between
Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type
Diffuse Gliomas: A Systematic Review.
Cancers
(Basel). 2023 Jan 5;15(2):364∟.
doi: 10.3390/cancers15020364∟.
PMID: 36672314∟.
Review. ˍ
Roux A, Zanello M, Simboli GA,
Varlet P, Tauziède-Espariat A, Beccaria K, Blauwblomme T,
Puget S, Oppenheim C, Dangouloff-Ros V, Boddaert N, Dhermain F,
Dufour C, Grill J, Chrétien F, Pallud
J.
Clinico-radio-histo-molecular
and neurocognitive characteristics of diffuse gliomas in
adolescent and young adults. A comprehensive review.
Oncology.
2023 Jan 5∟.
doi: 10.1159/000528588∟.
PMID: 36603564∟.
Review˰ ˍ
Halfpenny AM, Wood M.
Review
of the Recent Changes in the WHO Classification for Pediatric
Brain and Spinal Cord Tumors.
Pediatr
Neurosurg. 2023 Jan 6∟.
doi: 10.1159/000528957∟.
PMID: 36617415∟.
Review. ˍ
Tripathy A,
John V, Wadden J, Kong S, Sharba S, Koschmann C.
Liquid
biopsy in pediatric brain tumors.
Front
Genet. 2023 Jan 6, 2022;13:1114762∟. doi:
10.3389/fgene.2022.1114762∟.
PMID: 36685825∟.
Review. ˍ
Wang Y,
Bastiancich C, Newland B.
Injectable
local drug delivery systems for glioblastoma: a systematic review
and meta-analysis
of progress to date.
Biomater
Sci. 2023 Jan 6∟.
doi: 10.1039/d2bm01534j∟.
PMID: 36655634∟.
Review, Meta-analysis. ˍ
Ellingson BM, Wen PY, Chang SM, van
den Bent M, Vogelbaum MA, Li G, Li S, Kim J, Youssef G, Wick W,
Lassman AB, Gilbert MR, de Groot JF, Weller M, Galanis E,
Cloughesy TF.
Objective
response rate (ORR) targets for recurrent glioblastoma clinical
trials based on the historic association between ORR and median
overall survival.
Neuro
Oncol. 2023 Jan 7:noad002∟.
doi: 10.1093/neuonc/noad002∟.
PMID: 36617262∟.
Review. ˍ
Horbinski C, Nabors LB, Portnow J,
Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao
S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth
J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S,
Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K,
Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss
S, Wen PY, Willmarth NE, Bergman MA, Darlow S.
NCCN
Guidelines® Insights: Central Nervous System Cancers, Version
2.2022.
J Natl
Compr Canc Netw. 2023 Jan 10, 2023;21(1):12-20∟.
doi: 10.6004/jnccn.2023.0002∟.
PMID: 36634606∟.
Guidelines. ˍ
Oh KS, Mahalingam M.
Melanoma
and Glioblastoma-Not a Serendipitous Association.
Adv
Anat Pathol. 2023 Jan 10∟.
doi: 10.1097/PAP.0000000000000393∟.
PMID: 36624550∟.
Review˰ ˍ
Aseel A, McCarthy P, Mohammed
A.
Brain
magnetic resonance spectroscopy to differentiate recurrent
neoplasm from radiation necrosis: A systematic review and
meta-analysis.
J
Neuroimaging. 2023 Jan 11∟.
doi: 10.1111/jon.13080∟.
PMID: 36631883∟.
Review, Meta-analysis˰ ˍ
Bernstock JD, Blitz S, Kang KD,
Friedman GK.
Intraventricular
immunovirotherapy; a translational step forward.
Oncotarget.
2023 Jan 12, 2023;14:40-43∟.
doi: 10.18632/oncotarget.28343∟.
PMID: 36634220∟.
Perspective. ˍ
Caffo M, Minutoli L, Tabouret E,
Barresi V.
Editorial:
Novel diagnostic and therapeutic strategies in the management of
cerebral gliomas.
Front
Oncol. 2023 Jan 12;12:1115410∟.
doi: 10.3389/fonc.2022.1115410∟.
PMID: 36713581∟.
Editorial. ˍ
Capper D, Reifenberger G, French
PJ, Schweizer L, Weller M, Touat M, Niclou SP, Euskirchen P,
Haberler C, Hegi ME, Brandner S, Le Rhun E, Rudà R, Sanson
M, Tabatabai G, Sahm F, Wen PY, Wesseling P, Preusser M, van den
Bent MJ.
EANO
guideline on rational molecular testing of gliomas, glioneuronal
and neuronal tumors in adults for targeted therapy
selection.
Neuro
Oncol. 2023 Jan 12:noad008∟.
doi: 10.1093/neuonc/noad008∟.
PMID: 36632791∟.
Guidelines. ˍ
Johnson KJ, Bauchet L, Francis SS,
Hainfellner JA, Kruchko C, Lau CC, Ostrom QT, Scheurer ME, Yuan
Y.
Pediatric
brain tumors: Origins, epidemiology, and classification - The 2022
Brain Tumor Epidemiology Consortium meeting report.
Clin
Neuropathol. 2023 Jan 12∟.
doi: 10.5414/NP301520∟.
PMID: 36633374∟.
Meeting report˰ ˍ
Rodriguez-Almaraz JE, Butowski
N.
Therapeutic
and Supportive Effects of Cannabinoids in Patients with Brain
Tumors (CBD Oil and Cannabis).
Curr
Treat Options Oncol. 2023 Jan 12∟.
doi: 10.1007/s11864-022-01047-y∟.
PMID: 36633803∟.
Review. ˍ
Dalle Ore C,
Coleman-Abadi C, Gupta N, Mueller S.
Advances
and Clinical Trials Update in the Treatment of Diffuse Intrinsic
Pontine Gliomas.
Pediatr
Neurosurg. 2023 Jan 13∟.
doi: 10.1159/000529099∟.
PMID: 36642062∟.
Review. ˍ
Gombolay GY,
Gopalan N, Bernasconi A, Nabbout R, Megerian JT, Siegel B,
Hallman-Cooper J, Bhalla S, Gombolay MC.
Review
of Machine Learning and Artificial Intelligence (ML/AI) for the
Pediatric Neurologist.
Pediatr
Neurol. 2023 Jan 13;141:42-51∟.
doi: 10.1016/j.pediatrneurol.2023.01.004∟.
PMID: 36773406∟.
Review˰ ˍ
Kotecha R, Odia Y, Khosla AA,
Ahluwalia MS.
Key
Clinical Principles in the Management of Glioblastoma.
JCO
Oncol Pract. 2023 Jan 13:OP2200476∟.
doi: 10.1200/OP.22.00476∟.
PMID: 36638331∟.
Review. ˍ
Lu Q, Lu X,
Zhang Y, Huang W, Zhou H, Li T.
Recent
advances in ferroptosis and therapeutic strategies for
glioblastoma.
Front
Mol Biosci. 2023 Jan 13, 2022;9:1068437∟.
doi: 10.3389/fmolb.2022.1068437∟.
PMID: 36710875∟.
Review. ˍ
Shonka NA, Horbinski CM.
Reconciling
the Contemporary Molecular Diagnosis of Glioblastoma With Past
Clinical Trial Data.
JCO Oncol Pract. 2023 Jan
13:OP2200784∟.
doi: 10.1200/OP.22.00784∟.
PMID: 36638329∟.
Comment˰ ˍ
Refers
to:
Kotecha
R, et al., Key
Clinical Principles in the Management of Glioblastoma.
JCO
Oncol Pract. 2023 Jan 13:OP2200476∟.
doi: 10.1200/OP.22.00476∟.
PMID: 36638331∟.
Review. ˍ